| |
Premenopausal |
|
Postmenopausal |
|
| Specification |
Controls (n=15) |
Patients (n=30) |
P |
Controls (n=10) |
Patients (n=20) |
P |
| Free E2 % |
1.75±0.25 |
2.4±0.2 |
<0.00003 |
2.0 ±0.7 |
2.5±0.5 |
<0.005 |
| SHBG (nmol/litre) |
60.3±25.0 |
50.2±21.0 |
<0.001 |
60.9±18.9 |
45.1±9.1 |
<0.005 |
| Free T3 (pg/ml) |
6.9±0.5 |
5.1±0.7 |
<0.00015 |
6.4±2.1 |
4.9±1.5 |
<0.025 |
| Free T4 (pg/dl) |
1.2 ±0.27 |
0.9±0.2 |
<0.037 |
1.2±0.85 |
1.0±0.5 |
<0.05 |
| TSH (µunits/ml) |
1.08 ± 0.6 |
1.02±0.8 |
Not Significant |
1.22±0..5 |
1.11±0.7 |
NS |
| TBG (µg/ml)Controls |
20.7±3.2 |
19.0±2.8 |
Not significant |
20.7±3 |
18.2±4.7 |
NS |
|
